Moreover, a recent study showed that the Werner syndrome ATP-dependent helicase (WRN) may play a similar role as a synthetically lethal target in MMR deficient cancers258, thus WRN inhibition may be an alternative way to target these cancer cells. This evidence concerns the gene WRN and cancer.